Pediatric Sarcoma Research

American Association for Cancer Research | Annual Meeting Presentation | April 2024

Doctor holding yellow sarcoma ribbon.

Rein in Sarcoma is a nationally-known foundation which serves as a resource for patients and families touched by sarcomas. These are an uncommon and often misdiagnosed group of bone and soft tissue cancers, ones that impact children and adults alike.

We are proud to provide ongoing support to the University of Minnesota sarcoma researchers and investigators who have dedicated their careers to finding better treatments and ultimately a cure for sarcomas. Since 2001, we have funded over $2 million in innovative, collaborative and high-impact research and education initiatives at top medical research institutions such as Mayo Clinic, the University of Minnesota, and Children’s Hospitals and Clinics of Minnesota.

This is possible due to grants and generous donations from people like you.

This study investigates common pediatric sarcomas. The researchers aimed to understand the roles of both common and rare genetic variants in these cancers.

A note from Researcher, Dr. Logan Spector, PhD, University of Minnesota:

“I am mainly involved in trying to understand the causes of sarcomas, particularly Osteo and Ewing sarcoma, with a focus on germline genetic risk. Some surprising findings are that Ewing sarcoma unlike other sarcomas seems to be driven mainly by common genetic variation, whereas osteosarcoma and STS are driven more by rare, pathogenic variation.” Dr. Spector and his colleagues presented this research at the American Association for Cancer Research (AACR) conference in April, 2024.